Sector
PharmaceuticalsOpen
₹1,562.5Prev. Close
₹1,536.7Turnover(Lac.)
₹10,815.73Day's High
₹1,645Day's Low
₹1,537.1552 Week's High
₹1,595.452 Week's Low
₹1,004.45Book Value
₹290.26Face Value
₹10Mkt Cap (₹ Cr.)
6,676.5P/E
93.33EPS
16.46Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 36.88 | 36.44 | 36.44 | 31.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 638.23 | 550.35 | 481.57 | 132.45 |
Net Worth | 675.11 | 586.79 | 518.01 | 163.95 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Revenue | 520.13 | 340.6 |
yoy growth (%) | 52.7 | |
Raw materials | -272.83 | -179.68 |
As % of sales | 52.45 | 52.75 |
Employee costs | -41.36 | -20.98 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Profit before tax | 91.45 | 71.72 |
Depreciation | -10.08 | -4.18 |
Tax paid | -19.5 | -17.72 |
Working capital | 186.55 | |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | 52.7 | |
Op profit growth | 31.13 | |
EBIT growth | 26.52 | |
Net profit growth | 33.23 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 717.47 | 616.73 | 520.14 | 340.61 | 239.64 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 717.47 | 616.73 | 520.14 | 340.61 | 239.64 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 7.49 | 4.32 | 2.76 | 1.38 | 2.84 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,865.75 | 159.18 | 4,43,025.21 | 237.82 | 0.73 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,450.75 | 86.87 | 1,44,299.43 | 430 | 0.55 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,638.65 | 33.32 | 1,32,315.81 | 1,055.94 | 0.79 | 3,752.25 | 346.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,457.8 | 75.45 | 1,13,396.13 | 469 | 0.84 | 2,394 | 201.77 |
Dr Reddys Laboratories Ltd DRREDDY | 6,551.15 | 26.36 | 1,08,578.89 | 1,417.2 | 0.61 | 5,823.9 | 1,458.61 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director
Nareshbhai Ramjibhai Patel
Whole-time Director
Chetankumar Chhaganlal Vaghasia
Whole-time Director
Virendra Nath Mishra
Whole-time Director
Ram Mohan Rao Locande
Independent Non Exe. Director
Girikrishna Maniar
Independent Non Exe. Director
Hetal Gandhi
Independent Non Exe. Director
Richa M. Goyal
Independent Non Exe. Director
Anita Bandyopadhyay
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Ami Organics Ltd
Summary
Ami Organics Limited was initially formed as a partnership firm in the name of Ami Organics with effect from 03 January, 2004 at Surat, India. The Firm converted into a Private Limited Company under the name of Ami Organics Private Limited with a Certificate of Incorporation dated 12 June, 2007. Subsequently, the Company was converted into a Public Limited Company, following which the Companys name was changed to Ami Organics Limited, and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018.The Company is engaged in business of drugs intermediate chemicals and related activities. The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015. It increased warehouse capacity, equipped with modern infrastructure & a storage capacity of 1,050 MT of RM in 2017.The Company commenced its new Solvent Recovery Plant at Sachin in 2020. It acquired two units namely, the Ankleshwar and Jhagadia units from Gujarat Organics Limited (GOL) in 2021. The Company came out with an IPO which comprised a fresh issue of Rs 200 crore and an offer for sale of Rs 370 crore by shareholders, mopped up with a total of Rs 570 crore through its public issue in September, 2021. The Company incorporated wholly
Read More
The Ami Organics Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1631.3 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ami Organics Ltd is ₹6676.50 Cr. as of 20 Sep ‘24
The PE and PB ratios of Ami Organics Ltd is 93.33 and 5.35 as of 20 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Ami Organics Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Ami Organics Ltd is ₹1004.45 and ₹1595.4 as of 20 Sep ‘24
Ami Organics Ltd's CAGR for 5 Years at 10.45%, 3 Years at 8.97%, 1 Year at 20.41%, 6 Month at 37.01%, 3 Month at 12.21% and 1 Month at 20.30%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice